Muscle structural changes in mitochondrial myopathy relate to genotype

Journal of Neurology

Volumn 250, Issue 11, 2003, Pages 1328-1334

  Olsen, David B ^a   Langkilde, Annika R ^b   Ørngreen, Mette C ^a   Rostrup, Eigil ^b   Schwartz, Marianne ^a   Vissing, John ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Mitochondrial encephalomyopathies; Muscle morphology; Muscle MRI

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL MORPHOLOGY; GENE DELETION; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; MITOCHONDRIAL MYOPATHY; MUSCLE; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POINT MUTATION; PRIORITY JOURNAL; STRUCTURE ANALYSIS; THIGH;

ADIPOCYTES; CYTOCHROME-C OXIDASE DEFICIENCY; DNA, MITOCHONDRIAL; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MITOCHONDRIAL MYOPATHIES; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUTATION;

EID: 0345016025     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-003-0206-1     Document Type: Article

References (34)

1. Baur A, Reiser MF (2000) Diffusion weighted imaging of the musculo-skeletal system in humans. Skeletal Radiol 29:555-562
2. Bradley WG, Jones MZ, Mussini JM, Fawcett PR (1978) Becker-type muscular dystrophy. Muscle Nerve 1(2): 111-132
3. Cahill DR, Orland MJ, Miller GM (1995) Atlas of Human Cross-Sectional Anatomy. Third edition. Wiley-Liss, New York, pp 96-97
4. Carpenter S, Karpati G (2001) Major pathological reactions and their consequences for skeletal muscle cells. In: Carpenter S, Karpati G (eds) Pathology of skeletal muscle, second edition. Oxford University Press, New York, pp 63-130
5. Collins S, Dennett X, Byrne E (1995) Contrasting histochemical features of various mitochondrial syndromes. Acta Neurol Scand 91:287-293
6. Fleckenstein JL, Crues JV, Reimers CD (1996) Muscle imaging in health and disease. New York Springer, New York
7. Fleckenstein JL, Haller RG, Girson MS, Peshock RM (1992) Focal muscle lesions in mitochondrial myopathy: MR imaging evaluation. J Magn Reson Imaging 2 (Suppl 2):121 (abstract)
8. Giovanni SD, Mirabella M, Papacci M, et al. (2001) Apoptosis and ROS detoxification enzymes correlate with cytochrome c oxidase deficiency in mitochondrial encephalomyopathies. Mol Cell Neurosci 17:696-705
9. Goodpaster BH, Kelley DE, Thaete FL, et al. (2000) Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 89: 104-110
10. Goodpaster BH, Thaete FL, Simoneau J-A, Kelley DE (1997) Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46:1579-1585
11. Goto Y, Komiyama A, Tanabe Y, et al. (1990) Myopathy in Marinesco-Sjogren syndrome: an ultrastructural study. Acta Neuropathol (Berl) 80(2): 123-128
12. Gullotta F (1985) Metabolic myopathies. Pathol Res Pract 180(1): 10-18
13. Hardiman O (1994) Dystrophin deficiency, altered cell signaling and fibre hypertrophy. Neuromusc Disord 4(4): 305-315
14. Jensen TD, Kazemi-Esfarjani P, Skomorowska E, Vissing J (2002) A forearm exercise screening test for mitochondrial myopathy. Neurology 28(58): 1533-1538
15. Kelley DE, Slasky BS, Janosky J (1991) Skeletal muscle density: effects of obesity and non-insulin dependent diabetes mellitus. Am J Clin Nutr 54: 509-515
16. Koo B, Becker LE, Chuang S, et al. (1993) Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes (MELAS): clinical, radiological, pathological, and genetic observations. Ann Neurol 34:25-32
17. Lamminen AE (1990) Magnetic resonance imaging of primary skeletal muscle diseases: Patterns of distribution and severity of involvement. Br J Radiol 63:946-950
18. Miller RG, Sharma KR, Pavlath GK, et al. (1997) Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study. Muscle Nerve 20: 469-478
19. Mirabella M, Di Giovanni S, Silvestri G, et al. (2000) Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: a potential pathogenic mechanism. Brain 123: 93-104
20. Mitsui T, Kawai H, Nagassawa M, et al. (1996) Oxidative damage to skeletal muscle DNA from patients with mitochondrial encephalomyopathies. J Neurol Sci 139(1):111-116
21. Murphy WA, Totty WG, Carroll JE (1986) MRI of normal and pathologic skeletal muscle. Am J Radiol 146: 565-574
22. Petruzzella V, Moraes CT, Sano MC, Bonilla E, DiMauro S, Schon EA (1994) Extremely high levels of mutant mtDNAs co-localize with cytochrome coxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. Hum Mol Genet 3(3):449-454
23. Phoenix J, Betal D, Roberts N, et al. (1996) Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve 19:302-310
24. Ravn K, Wibrand F, Hansen FJ, et al. (2001) An mtDNA mutation, 14453G→A, in the NADH dehydrogenase subunit 6 associated with severe MELAS syndrome. Eur J Hum Genet 9:805-809
25. Reichmann H, Gold R, Meurers B, et al. (1993) Progression of myopathology in Kearns-Sayre syndrome: a morphological follow-up study. Acta Neuropathol (Berl) 85(6):679-681
26. Schapira AHV (2000) Mitochondrial disorders. Curr Opin Neurol 13: 527-532
27. Schroder JM, Krabbe B, Weis J (1995) Oculopharyngeal muscular dystrophy: clinical and morphological follow-up study reveals mitochondrial alterations and unique nuclear inclusions in a severe autosomal recessive type. Neuropathol Appl Neurobiol 21(1): 68-73
28. Schwartz M, Vissing J (2002) Paternal inheritance of mitochondrial DNA. N Engl J Med 347(8):576-580
29. Shoffner JM, Shoubridge EA (2001) Oxidative phosphorylation diseases of muscle. In: Karpati G, Hilton-Jones D and Griggs RC editors. Disorders of voluntary muscles seventh edition. Cambridge: Cambridge University Press, pp 580-603
30. 2 and nitric oxide-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblasts. J Neuropathol Exp Neurol 55:36-43
31. Vissing J (2002) Mitochondrial myopathies. In: Skeletal Muscle: Pathology, Diagnosis and Management Disease. In: Preedy VR, Peters TJ (eds) London: Greenwich Medical Media Ltd. chapter 14, pp 153-166
32. Vissing J, Haller RG (2001) Metabolic myopathies. In: Pourmand R (ed) Neuromuscular Disease: Expert Clinician's Views. Boston: Butterworth Heinemann, pp 393-410
33. met gene mutation in a patient with dystrophic muscle and exercise intolerance. Neurology 50:1875-1878
34. Wallace DC (1999) Mitochondrial disease in man and mouse. Science 283: 1482-1488